Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Agnelli, G; Becattini, C; Meyer, G; Munoz, A; Huisman, MV; Connors, JM; Cohen, A; Bauersachs, R; Brenner, B; Torbicki, A; Sueiro, MR; Lambert, C; Gussoni, G; Campanini, M; Fontanella, A; Vescovo, G; Verso, M; Caravaggio Investigators.

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

NEW ENGLAND JOURNAL OF MEDICINE. 2020; 382(17): 1599-1607 Nº de citas: 713 [doi:10.1056/NEJMoa1915103]

Martin, AJM; Ramirez, SP; Moran, LO; Zamorano, MR; Beneitez, MCV; Salcedo, IA; Escobar, IG; Fernandez, JMS.

Pharmacological cancer treatment and venous thromboembolism risk

EUROPEAN HEART JOURNAL SUPPLEMENTS. 2020; 22(C): 2-14 Nº de citas: 12 [doi:10.1093/eurheartj/suaa004]

Martin-Broto, J; Hindi, N; Lopez-Pousa, A; Peinado-Serrano, J; Alvarez, R; Alvarez-Gonzalez, A; Italiano, A; Sargos, P; Cruz-Jurado, J; Isern-Verdum, J; Dolado, MC; Rincon-Perez, I; Sanchez-Bustos, P; Gutierrez, A; Romagosa, C; Morosi, C; Grignani, G; Gatti, M; Luna, P; Alastuey, I; Redondo, A; Belinchon, B; Martinez-Serra, J; Sunyach, MP; Coindre, JM; Dei Tos, AP; Romero, J; Gronchi, A; Blay, JY; Moura, DS.

Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas A Nonrandomized Phase 1/2 Clinical Trial

JAMA Oncology. 2020; 6(4): 535-541 Nº de citas: 38 [doi:10.1001/jamaoncol.2019.6584]

Trilla-Fuertes, L; Ghanem, I; Gamez-Pozo, A; Maurel, J; G-Pastrian, L; Mendiola, M; Pena, C; Lopez-Vacas, R; Prado-Vazquez, G; Lopez-Camacho, E; Zapater-Moros, A; Heredia, V; Cuatrecasas, M; Garcia-Alfonso, P; Capdevila, J; Conill, C; Garcia-Carbonero, R; Ramos-Ruiz, R; Fortes, C; Llorens, C; Nanni, P; Vara, JAF; Feliu, J.

Genetic Profile and Functional Proteomics of Anal Squamous Cell Carcinoma: Proposal for a Molecular Classification

MOLECULAR & CELLULAR PROTEOMICS. 2020; 19(4): 690-700 Nº de citas: 5 [doi:10.1074/mcp.RA120.001954]

Muñoz Martín AJ; Ruiz Zamorano MC; Viñuela Benéitez MC; Ortega Morán L; García Pérez Á; Martín Jiménez M.

Outpatient management of incidental pulmonary embolism in cancer patient

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(4): 612-615 Nº de citas: 8 [doi:10.1007/s12094-019-02153-4]

Fox, B; de Toro Carmena M; Alvarez, RA; Calles Blanco A; Lopez, CL; Pérez Ramírez S; Arranz, JA; Martin, M; Marquez-Rodas, I.

Efficacy and safety of immune checkpoint inhibitor immunotherapy in elderly cancer patients

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(4): 555-562 Nº de citas: 12 [doi:10.1007/s12094-019-02161-4]

Rugo, HS; Finn, RS; Gelmon, K; Joy, AA; Harbeck, N; Castrellon, A; Mukai, H; Walshe, JM; Mori, A; Gauthier, E; Lu, DR; Bananis, E; Martin, M; Dieras, V.

Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: Analysis From PALOMA-2

CLINICAL BREAST CANCER. 2020; 20(2): 173-180 Nº de citas: 24 [doi:10.1016/j.clbc.2019.08.009]

Chau, I; Fakih, M; Garcia-Alfonso, P; Linke, Z; Casado, AR; Marques, EP; Picard, P; Celanovic, M; Cartwright, T.

Safety and Effectiveness of Aflibercept plus Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study

Cancers. 2020; 12(3): Nº de citas: 11 [doi:10.3390/cancers12030657]

Jimenez, GD; Amo, FH; Arija, JAA; Fernandez, ER; Rios, DS; Garcia, EL; Chomon, GB; Gil, MJC; Rodriguez, JC; Fernandez, CH.

Effect of adjuvant chemotherapy in locally advanced urothelial carcinoma of the bladder treated with cystectomy

Actas Urologicas Espanolas. 2020; 44(2): 94-102 Nº de citas: 5 [doi:10.1016/j.acuro.2019.08.009]

Becattini, C; Verso, M; Munoz, A; Agnelli, G.

Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients

HAEMATOLOGICA. 2020; 105(3): 838-848 Nº de citas: 23 [doi:10.3324/haematol.2019.221424]

Bendell, JC; Sauri, T; Gracian, AC; Alvarez, R; Lopez-Lopez, C; Garcia-Alfonso, P; Hussein, M; Miron, MLL; Cervantes, A; Montagut, C; Vivas, CS; Bessudo, A; Plezia, P; Moons, V; Andel, J; Bennouna, J; van der Westhuizen, A; Samuel, L; Rossomanno, S; Boetsch, C; Lahr, A; Franjkovic, I; Heil, F; Lechner, K; Krieter, O; Hurwitz, H; McCAVE Study Group.

The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

ONCOLOGIST. 2020; 25(3): 451-459 Nº de citas: 34 [doi:10.1634/theoncologist.2019-0291]

Roldan-Romero, JM; Beuselinck, B; Santos, M; Rodriguez-Moreno, JF; Lanillos, J; Calsina, B; Gutierrez, A; Tang, K; Lainez, N; Puente, J; Castellano, D; Esteban, E; Climent, MA; Arranz, JA; Albersen, M; Oudard, S; Couchy, G; Caleiras, E; Montero-Conde, C; Cascon, A; Robledo, M; Rodriguez-Antona, C; Garcia-Donas, J; Pinto, A; Hernando-Polo, S; Grande, E; Domenech, M; Virizuela, JA; Saez, MI; Rodriguez-Lajusticia, L; Duran, I; Gonzalez-Billalabeitia, E; Gallardo, E; del Alba, AG; Bellmunt, J; Mellado, B; Font, A; Alonso-Gordoa, T; Spanish Oncology Genitourinary Grp.

PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma

INTERNATIONAL JOURNAL OF CANCER. 2020; 146(5): 1435-1444 Nº de citas: 23 [doi:10.1002/ijc.32579]

Slamon, DJ; Neven, P; Chia, S; Fasching, PA; De Laurentiis, M; Im, SA; Petrakova, K; Bianchi, GV; Esteva, FJ; Martin, M; Nusch, A; Sonke, GS; De la Cruz-Merino, L; Beck, JT; Pivot, X; Sondhi, M; Wang, YB; Chakravartty, A; Rodriguez-Lorenc, K; Taran, T; Jerusalem, G.

Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer

NEW ENGLAND JOURNAL OF MEDICINE. 2020; 382(6): 514-524 Nº de citas: 577 [doi:10.1056/NEJMoa1911149]

Hurvitz, SA; Martin, M; Press, MF; Chan, D; Fernandez-Abad, M; Petru, E; Rostorfer, R; Guarneri, V; Huang, CS; Barriga, S; Wijayawardana, S; Brahmachary, M; Ebert, PJ; Hossain, A; Liu, JG; Abel, A; Aggarwal, A; Jansen, VM; Slamon, DJ.

Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2(-) Breast Cancer

CLINICAL CANCER RESEARCH. 2020; 26(3): 566-580 Nº de citas: 175 [doi:10.1158/1078-0432.CCR-19-1425]

Rugo, HS; Ettl, J; Hurvitz, SA; Goncalves, A; Lee, KH; Fehrenbacher, L; Mina, LA; Diab, S; Woodward, NE; Yerushalmi, R; Goodwin, A; Blum, JL; Martin, M; Quek, RGW; Tudor, IC; Bhattacharyya, H; Gauthier, E; Litton, JK; Eiermann, W.

Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy

Jnci Cancer Spectrum. 2020; 4(1): Nº de citas: 25 [doi:10.1093/jncics/pkz085]

Lazaro, M; Valderrama, BP; Suarez, C; de-Velasco, G; Beato, C; Chirivella, I; Gonzalez-Del-Alba, A; La?nez, N; M?ndez-Vidal, MJ; Arranz, JA.

SEOM clinical guideline for treatment of kidney cancer (2019)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(2): 256-269 Nº de citas: 16 [doi:10.1007/s12094-019-02285-7]

Jerez, Y; Marquez-Rodas, I; Aparicio, I; Alva, M; Mart?n, M; L?pez-Tarruella, S.

Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations

DRUGS. 2020; 80(2): 131-146 Nº de citas: 10 [doi:10.1007/s40265-019-01235-5]

Martin, AJM; Diaz, EG; Escobar, IG; Montero, RM; Martinez-Marin, V; Olmos, VP; Segura, PP; Verduguez, TQ; Fernandez, MS.

SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(2): 171-186 Nº de citas: 39 [doi:10.1007/s12094-019-02263-z]